WO1998051801A1 - Gene encoding for systemic acquired resistance in arabidopsis - Google Patents
Gene encoding for systemic acquired resistance in arabidopsis Download PDFInfo
- Publication number
- WO1998051801A1 WO1998051801A1 PCT/US1998/009863 US9809863W WO9851801A1 WO 1998051801 A1 WO1998051801 A1 WO 1998051801A1 US 9809863 W US9809863 W US 9809863W WO 9851801 A1 WO9851801 A1 WO 9851801A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- sar
- plant
- plants
- protein
- dir
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8281—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for bacterial resistance
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
Definitions
- This invention relates to a gene specific to the signal transduction pathway for systemic acquired resistance in plants.
- SAR Systemic Acquired Resistance
- the signal transduction pathway in plants that leads to Systemic Acquired Resistance (SAR) involves a number of stages
- the first stage is the induction or immunization stage, where initial infection of a leaf by a pathogen to which the plant is resistant results in a hypersensitive response (HR) leading to the formation of necrotic lesions
- HR hypersensitive response
- SAR occurs without necrosis Cameron, et al , "Biologically induced systemic acquired resistance in Arabidopsis thahana " Plant J 5 715-725 (1 94), Keller, et al , "Physiological and molecular characteristics of elicitin-induced systemic acquired resistance in tobacco," Plant Physiol 110 365-376 (1996)
- PR pathogenesis-related
- the second stage in the signal transduction pathway that leads to SAR is the establishment stage, which involves the perception of the mobile signal in systemic leaves It is characterized by the expression of the same set of SAR genes as induced around the primary necrotic lesion, as well as the accumulation of salicylic acid, although to lower levels than are induced in the primary leaf during the induction stage
- the final stage in the signal transduction pathway is the expression stage which occurs when the plant is challenged with a second, normally virulent, pathogen and responds to that pathogen as if it were an avirulent one Kuc', J , Biosaence 32 854-856 (1982)
- Arabidopsis mutant that is nonresponsive to inducers of systemic acquired resistance Plant Cell 6 1583-1592 (1994) also show enhanced disease susceptibility to virulent pathogens, confirming the role of salicylic acid in general disease resistance
- Mutant cprl plants (constitutive expressor of PR genes) with elevated levels of SAR gene expression and salicylic acid were shown to be resistant to normally virulent pathogens (Bowling, et al , "A mutation in Arabidopsis that leads to constitutive expression of systemic acquired resistance,” Plant Cell 6 1845-1857 (1994)), providing further genetic evidence in support of the importance of salicylic acid accumulation in disease resistance
- a number of Arabidopsis mutants affected in their ability to establish SAR have been isolated However, these mutants also have a reduced general defense response, and therefore, the lesion in these plants is not specific for SAR
- LTP's Lipid transfer proteins
- LPT's have also been identified as important in the establishment of SAR in plants
- LPT's have been cloned from a number of plant species, and have been proposed to function in a range of processes including embryogenic development and epicuticular wax deposition (Pyee and Kolattukudy, "The gene for the major cuticular wax-associated protein and three homologous genes from broccoli (Brassica oleraced) and their expression patterns," Plant Journal 7 49-59 (1995), Toonen et al , “AtLTPl luciferase expression during carrot somatic embryogenesis,” P/ ⁇ wt Jowr/r ⁇ / 12 1213-1221 (1997))
- LTPs have already been implicated in plant defense responses.
- LTPs from two monocot species were shown to possess antimicrobial activity (Molina et al., "Lipid transfer proteins (nsLTPs) from barley and maize leaves are potent inhibitors of bacterial and fungal plant pathogens," FEBS Letters 316: 119-122 (1993)), and transgenic tobacco and Arabidopsis genetically engineered to express a barley LTP were shown to exhibit enhanced tolerance against pathogens (Molina and Garcia-Olmedo, "Enhanced tolerance to bacterial pathogens caused by the transgenic expression of barley lipid transfer protein LTP2," Plant Journal 12: 669-675 (1997)). These lipid transfer proteins have not been shown to function in SAR signal transduction.
- genes which code for proteins which act upstream from salicylic acid in the signal transduction pathway affect SAR in plants and a method for isolating those genes is herein disclosed.
- the dir-1 gene which encodes a novel lipid transfer protein which is involved in the signal transduction pathway, has now been isolated and characterized.
- the gene is useful as a reagent for determining the mechanisms involved in establishing SAR in plants, and for genetically engineering disease-resistance in plants.
- a method for genetic screening of SAR mutants has also been developed which allows for detection of SAR-defective mutants throughout the SAR signal transduction pathway, and more specifically, for those SAR mutants which encode proteins which act upstream of where salicylic acid acts in the SAR signal transduction pathway.
- Proteins translated from the genes are useful for the production of antibodies to the proteins.
- the antibodies are useful as reagents in screening plants for examples of the SAR signal transduction genes.
- the present invention is directed to a nucleic acid molecule encoding a protein capable of enhancing systemic acquired resistance in a plant.
- the protein acts upstream from where salicylic acid acts along the signal transduction pathway.
- the invention is also directed to a vector nucleic acid comprising the dir-1 gene.
- the invention further comprises plant cells transformed with a vector containing the dir-1 gene.
- This invention further comprises a method for conferring systemic acquired resistance to a plant.
- the invention also comprises a method for isolating SAR mutants which encode proteins which act upstream of salicylic acid in the signal transduction pathway.
- Fig. 1 depicts the nucleotide sequence of the dir-1 gene.
- Fig. 2 depicts the amino acid sequence of the dir-1 lipid transfer protein.
- the present invention involves the isolation of genes involved in SAR signal transduction which encode proteins which act upstream from where salicylic acid acts along the SAR signal transduction pathway.
- To isolate a gene involved in SAR signal transduction which encodes a protein which acts upstream from where salicylic acid acts along the pathway the following method is used Using techniques as described in Example 1 , wild type and T-DNA transformed plants are grown and observed for disease symptoms SAR mutants are isolated, and SAR competence tests are performed as described in Example 1 The SAR mutants are then tested to determine the position of the mutant gene in relation to the point of salicylic acid action in the pathway as described in Example 1
- DNA is isolated from those plants which are homozygous for a SAR mutant gene, and where the gene is found to encode a protein which acts upstream from the site of salicylic acid action along the pathway, probed to isolate a cDNA, and sequenced using techniques as described in Example 2
- the isolated genes, such as the dir-1 gene can be used as vectors to transform plants for improved disease resistance by restoring
- Transformed plants may be regenerated by standard protocols well known to those with average skill in the art, such as organogenesis from leaf discs or somatic embryogenesis
- the transformed plants may be propagated sexually, or by cell or tissue culture
- the invention includes the expression of the proteins translated from the isolated genes such as the dir-1 gene
- These proteins, such as the dir-1 lipid transfer protein (dir-1 LTP) are useful in developing antibodies to the protein
- the antibodies are valuable reagents to be used in the process of screening plants for the expression of isolated genes such as the dir-1 gene
- To isolate a protein from a SAR signal transduction pathway gene the gene product of the isolated gene is expressed as described in Example 5
- Antibodies to the protein are produced as described in Example 6
- the antibodies to the protein are used as reagents for screening of plants for expression of the isolated gene as described in Example 6
- This invention includes a method for screening SAR-defective mutants throughout the SAR signal transduction pathway, and, more specifically, for screening for those mutants of genes which encode proteins which act upstream from where salicylic acid acts along the pathway After transforming plants and then observing those plants for disease symptoms as described in Example 1, SAR mutants are isolated The SAR mutants are then tested to determine the position of the mutant gene in relation to the point of salicylic acid action in the pathway as described in Example 1
- a number of dir-1 M2 plants were backcrossed to wild-type Ws and the resulting FI, F2, and F3 progeny subjected to a SAR competence test (described below) in order to determine whether the dir-1 mutation was recessive or dominant to wild-type, and also if the dir-1 phenotype cosegregated with the T-DNA (kanamycin resistance marker).
- the control treatment consisted of a primary inoculation with 10 mM MgCl 2 on one leaf per plant, followed two days later by another inoculation with 10 mM MgCl 2 on four other leaves/plant.
- An avirulent treatment consisted of a primary inoculation with 10 mM MgCl 2 on one leaf per plant, followed two days later by an avirulent inoculum (10 6 cfu/ml) on four other leaves/plant.
- a virulent treatment (M,V) consisted of a primary inoculation with 10 mM MgCl 2 on one leaf/plant, followed two days later by a virulent inoculum (10 6 cfu/ml) on four other leaves per plant.
- a SAR treatment (AN) consisted of a primary inoculation with avirulent bacteria (10 6 cfu/ml) on one leaf/plant, followed two days later with a virulent inoculum (10 6 cfu/ml) on four other leaves/plant. Disease symptoms or their absence were noted for each treatment, and results confirmed by collecting leaf discs from each treatment for determination of nplanta bacterial growth
- Salicylic acid was determined by grinding 0 5 g of Arabidopsis leaf tissue (20-30 leaves) in liquid N 2 , then extracting in 50% ethanol plus 0 04% 2-mercapto- ethanol, followed by two volumes of 100% ethanol plus 0 04% 2-mercaptoethanol
- Samples of total RNA (5 ⁇ g) were separated by electrophoresis through formaldehyde-agarose gels and blotted to Hybond-N nylon membranes (Amersham Corp , Arlington Heights, IL) as described in Sambrook, et al., Molecular Cloning, A Laboratory Manual, 2nd ed , Cold Spring Harbor Laboratory Press, pp 7.43-7 46 (1989).
- Ethidium bromide 40 ⁇ g/ml was included in the sample buffer in order to confirm equal sample loading under UV light after electrophoresis.
- PR-1, PR-2 and PR-5 were 32 P- labeled by random priming using a Random Primer Kit (Amersham). Hybridizations and washes were carried out according to Church, G.M. and Gilbert, W , "Genomic sequencing,” Proc Natl AcadSci USA 81:1991-1995 (1984). A rDNA probe was used to reconfirm that each lane was loaded with similar levels of total RNA.
- the backcrossed dir-1 lines were allowed to set seed and were plated out (250-500 seeds) on kanamycin-containing media to determine if the SAR defective phenotype segregated with the kanamycin resistance gene present on the T-D ⁇ A to determine whether the dir-1 mutation was the result of insertion of the T-D ⁇ A into the dir-1 gene.
- Seven backcrossed F2 lines were analyzed. Segregation ratios (kanamycin resistant to kanamycin sensitive) ranged from 7 to 3.3, indicating that there was at one time more than one T-DNA insertion per plant. If there were two functional copies of the T-DNA present in these lines, the ratio of kanamycin resistant to sensitive plants would be 15:1.
- F2 lines kanamycin resistant and sensitive
- F2 lines were transferred to soil, grown for four weeks, then tested for SAR competence by measurement of disease symptoms and bacterial growth levels. Very few of the kanamycin sensitive plants grew when transferred to soil, but for the most part, these plants were SAR competent. Plants from the F2 lines which grew on kanamycin ranged from 100% SAR defective as expected to 80% SAR defective, indicating that there was a functional kanamycin resistance gene in some of the progeny that was not linked to the dir-1 mutation.
- DNA was isolated from both SAR defective, kanamycin resistant F2 plants and from SAR competent, kanamycin sensitive F2 plants.
- the DNA from each sample was digested with EcoRl and subjected to electrophoresis, blotting, and probing with the plasmid pBR322, which is contained within the T-DNA construct.
- Errampalli, et al. "Embryonic lethals and T-DNA insertional mutagenesis in Arabidopsis," Plant Cell 3:149-157 (1991).
- a number of the F2 SAR defective, kanamycin resistant plants contained bands corresponding to the T-DNA that were not found in the SAR competent, kanamycin sensitive plants.
- a number of these dir-1 F2 kanamycin resistant plants were backcrossed again to wild-type Ws in order to eliminate any non-linked T-DNA sequences.
- a SAR competence test was performed on individuals from two families that grew on kanamycin-containing media; if the T-DNA cosegregates with the dir-1 phenotype, all individuals are SAR defective. Each individual in both families (approximately 120) was SAR defective as measured by phenotype and bacterial quantification.
- kanamycin sensitive F3 plants were homozygous wild-type for dir-1, and expressed SAR.
- the genetic analysis therefore indicates that the dir- 1 mutation is caused by the insertion of a T-DNA, facilitating the strategy of cloning the interrupted gene by polymerase chain reaction (PCR) techniques.
- PCR polymerase chain reaction
- Pst collect inoc or uninoc leaves after 2nd challenge.
- 4 (AN) Primary inoculation - avirulent Pst; 2nd inoculation - virulent Pst; collect inoculated leaves after 2nd challenge.
- Genomic D ⁇ A was isolated from leaves of a dir-1 homozygous line by standard procedures (Sambrook, et al., Molecular Cloning, A Laboratory Manual, 2nd ed., Cold Spring Harbor Laboratory Press (1989).
- Application of thermal assymetric interlaced (TAIL) PCR (Liu et al., "Efficient isolation and mapping of Arabadopsis thaliana T-D ⁇ A insert junctions by thermal assymetric interlaced PCR", Plant Journal 8: 457-463 (1995)) using primers specific for the right border (RB) of the T-D ⁇ A resulted in cloned sequences containing the RB but, instead of plant flanking D ⁇ A, inverted T-D ⁇ A sequences were found, indicating that a rearrangement had occurred within the T-D ⁇ A leading to an insert with two left borders (LBs).
- TAIL-PCR was then performed using primers designed to anneal to the LB of the T-DNA Two specific sequences were amplified
- DNA was sequenced by the Sanger dideoxy sequencing method (Sanger, et al , Proc NatlAcadSci USA 74 5463-5467 (1977)) A Taq Dideoxy Terminator Cycle Sequencing Kit (Applied Biosystems Inc , Foster City, CA) was used according to the manufacturer's protocol The products were separated on a 6% polyacrylamide gel and the data processed by an ABI 373 A automated DNA sequencer All manipulations of raw data generated from the automated system were done on the PC Gene DNA analysis software (Intelligenetics, Mountain View, CA)
- SEQ ID NO 1 Evidence indicates that the Arabidopsis LTP encoded by dir-1 is a novel protein involved in signal transduction for establishing systemic plant immunity to disease Firstly, the nature of the genetic screen targeted mutations in systemic rather than local responses, and this was borne out by the fact that the dir-1 mutation does not affect the local response to avirulent pathogens or the level of susceptibility to virulent pathogens in naive plants, as would occur if the dir-1 gene product was in itself antimicrobial. Secondly, inducers of SAR such as INA rescue the dir-1 phenotype, indicating that dir-1 is upstream of other signal functions such as nprl, mutations which eliminate responsiveness to INA (Cao et al.,
- the T-DNA insertion in the 3 '-untranslated region of dir-1 leads to a reduction in corresponding transcript levels and therefore reduced levels of functional dir-1 LTP. This, in turn, blocks signal transduction from the primary infected leaf to systemic leaves of the plant.
- the identification of the dir-1 gene having dir-1 LTP as a translation product indicates that lipid intermediates act as systemic signals in SAR.
- the amino acid sequence for the dir-1 LPT was derived using PC Gene software and is given in SEQ ID NO: 2.
- Fragments containing the full length Arabidopsis dir-1 cDNA, or a functional homolog of dir-1 from another plant species, are cloned in a binary vector plasmid, for example in place of the GUS gene in the binary vector plasmid pBI121.1 (R. A. Jefferson, T. A. Kavanagh, M. W.
- Tobacco and alfalfa plants are transformed with A. tumefaciens strain LBA4404 harboring the dir-1 gene construct by leaf disc methods
- Transgenic tobacco plants (Nicotiana tabacum cv Xanthi NF) are generated as described before (Rogers, et al , "Gene transfer in plants Production of transformed plants using Ti plasmid vectors," Methods Enzymol 118 627-640 (1986)), with regeneration under kanamycin selection
- Transgenic alfalfa plants are generated from the transformation and regeneration of competent alfalfa cultivar Regen S Y (Bingham, E T , "Registration of alfalfa hybrid Regen-SY germplasm for tissue culture and transformation research," Crop Sci 31 1098 (1991)), following a modified version of published procedures (Bingham, et al , "Breeding alfalfa which regenerates from callus tissue in culture,” Crop Sci 15 719-721 (1975)) Briefly, leaf discs from young trifoli
- the Arabidopsis dir-1 gene product is expressed in E. coli SB221 cells as described (BS Shorrosh and RA Dixon, "Molecular cloning of a putative plant endomembrane protein resembling vertebrate protein disulfide isomerase and phosphatidylinositol-specific phospholipase C," Proc Natl Acad of Sci USA 88: 10941-10945).
- the expressed protein is resolved by polyacrylamide gel electrophoresis (Laemmli, U.K., "Cleavage of structural proteins during the assembly of the head of bacteriophage T4, N ⁇ twre 227: 680-685 (1970)).
- the protein band encoded by dir-1 is localized by staining with Coomassie brilliant blue, and regions from 12 gel lanes excised, cut into small fragments, destained to completion with 50% (v/v) isopropanol/3% (w/v) SDS overnight, rinsed with water, vacuum dried, ground in liquid nitrogen, and finally resuspended in phosphate buffered saline.
- Antiserum is obtained by immunizing a female New Zealand White rabbit.
- the primary immunization contains approximately 30 ⁇ g of the dir-1 LTP in 2.7 ml of complete Freund's adjuvant, injected subcutaneously along the back at nine separate sites (300 ml per site).
- Booster injections containing dir-1 LTP from six excised gel lanes (approximately 15 ⁇ g) in incomplete Freund's adjuvant are given at 4 and 6 weeks after the primary injections.
- the serum is stored at - 20°C.
- the antibodies are used as a reagent to detect the dir-1 LTP in transgenic plants in a Western blot analysis.
- Leaf and stem proteins are extracted in 0.2 M borate buffer, pH 8.8 and subjected to denaturing polyacrylamide gel electrophoresis by standard procedures (Ausubel et al. 1994. Current Protocols in Molecular Biology, John Wiley and Sons, Inc., New York). Proteins are transferred to Immobilon-P membranes (Millipore, Milford, MA) in 25 mM Tris- HC1, pH 8.3, 192 mM glycine, and 20% methanol (Towbin et al. 1979.
- GAG TGC AAA CCA GCG GTT AGC AAG GAG AAT CCG ACG AGC CCA TCA CAG 197 Glu Cys Lys Pro Ala Val Ser Lys Glu Asn Pro Thr Ser Pro Ser Gin 40 45 50
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP54954498A JP2001525674A (en) | 1997-05-14 | 1998-05-14 | Gene encoding systemic acquired resistance of Arabidopsis |
| EP98922292A EP0981623A1 (en) | 1997-05-14 | 1998-05-14 | Gene encoding for systemic acquired resistance in arabidopsis |
| IL13276298A IL132762A0 (en) | 1997-05-14 | 1998-05-14 | Gene encoding for systemic acquired resistance arabidopsis |
| AU74875/98A AU7487598A (en) | 1997-05-14 | 1998-05-14 | Gene encoding for systemic acquired resistance in arabidopsis |
| NZ500887A NZ500887A (en) | 1997-05-14 | 1998-05-14 | Nucleic acid encoding lipid transfer protein which exhibits SAR (systemic acquired resistance) by specific process |
| CA002289751A CA2289751A1 (en) | 1997-05-14 | 1998-05-14 | Gene encoding for systemic acquired resistance in arabidopsis |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4647597P | 1997-05-14 | 1997-05-14 | |
| US60/046,475 | 1997-05-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO1998051801A1 true WO1998051801A1 (en) | 1998-11-19 |
Family
ID=21943674
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US1998/009863 Ceased WO1998051801A1 (en) | 1997-05-14 | 1998-05-14 | Gene encoding for systemic acquired resistance in arabidopsis |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0981623A1 (en) |
| JP (1) | JP2001525674A (en) |
| AU (1) | AU7487598A (en) |
| CA (1) | CA2289751A1 (en) |
| IL (1) | IL132762A0 (en) |
| NZ (1) | NZ500887A (en) |
| WO (1) | WO1998051801A1 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6512163B1 (en) | 1997-09-15 | 2003-01-28 | Institute Of Molecular Agrobiology | RANK1, an ankyrin-repeat containing peptide from rice associated with disease resistance |
| WO2015017786A1 (en) * | 2013-08-02 | 2015-02-05 | Cornell University | Increasing leaf longevity and disease resistance by altering salicylic acid catabolism |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992020801A1 (en) * | 1991-05-24 | 1992-11-26 | Universidad Politecnica De Madrid | Novel antipathogenic peptides and compositions containing same |
| WO1997023617A1 (en) * | 1995-12-21 | 1997-07-03 | Novartis Ag | Antimicrobial proteins |
-
1998
- 1998-05-14 AU AU74875/98A patent/AU7487598A/en not_active Abandoned
- 1998-05-14 WO PCT/US1998/009863 patent/WO1998051801A1/en not_active Ceased
- 1998-05-14 JP JP54954498A patent/JP2001525674A/en active Pending
- 1998-05-14 CA CA002289751A patent/CA2289751A1/en not_active Abandoned
- 1998-05-14 IL IL13276298A patent/IL132762A0/en unknown
- 1998-05-14 EP EP98922292A patent/EP0981623A1/en not_active Withdrawn
- 1998-05-14 NZ NZ500887A patent/NZ500887A/en unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992020801A1 (en) * | 1991-05-24 | 1992-11-26 | Universidad Politecnica De Madrid | Novel antipathogenic peptides and compositions containing same |
| WO1997023617A1 (en) * | 1995-12-21 | 1997-07-03 | Novartis Ag | Antimicrobial proteins |
Non-Patent Citations (10)
| Title |
|---|
| BOWLING, S.A., ET AL.: "A mutation in Arabidopsis that leads to constitutive expression of systemic acquired resistance", THE PLANT CELL, vol. 6, December 1994 (1994-12-01), pages 1845 - 1857, XP002075327 * |
| CAMERON, R.K., ET AL.: "Biologically induced systemic acquired resistance in Arabidopsis thaliana", THE PLANT JOURNAL, vol. 5, no. 5, 1994, pages 715 - 725, XP002074728 * |
| CAMERON, R.K., ET AL.: "Isolation of Arabidopsis mutants affected in the establishment of biologically induced systemic acquires resistance", JOUNAL OF CELLULAR BIOCHEMISTRY SUPPLEMENT, vol. 18A, 1994, pages 92, XP002074729 * |
| CENTURY, K.S.: "Genetic and molecular analysis of disease resistance in Arabidopsis thaliana", PHD THESIS. UNIVERSITY OF CALIFORNIA, BERKELEY, 1996, XP002074727 * |
| CHOI, D.-W., ET AL.: "Isolation of a root-specific cDNA encoding a ns-LTP-like protein from the roots of bean (Phaseolus vulgaris L.) seedlings", PLANT MOLECULAR BIOLOGY, vol. 30, 1995, pages 1059 - 1066, XP002074732 * |
| DELANEY, T.P., ET AL.: "Genetic dissection of acquired resistance to disease", PLANT PHYSIOLOGY, vol. 113, January 1997 (1997-01-01), pages 5 - 12, XP002074731 * |
| DIETRICH, R.A., ET A.: "Arabidopsis mutants simulating disease resistance response", CELL, vol. 77, 1994, pages 565 - 577, XP002075328 * |
| PARKER, J.E., ET AL.: "Characterization of eds1, a mutation in Arabidopsis suppressing reistance to Peronospora parasitica specified by several different RPP genes", THE PLANT CELL, vol. 8, November 1996 (1996-11-01), pages 2033 - 2046, XP002074726 * |
| RYALS, J.A., ET AL.: "Systemic acquired resistance", THE PLANT CELL, vol. 6, October 1996 (1996-10-01), pages 1809 - 1819, XP002075329 * |
| VERNOOIJ, B., ET AL.: "2,6-didichloroisonicotinic acid-induced resistance to pathogens without the accumulation of salicylic acid", MOL. PLANT-MICROBE INTERACT., vol. 8, no. 2, 1995, pages 228 - 234, XP002075162 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6512163B1 (en) | 1997-09-15 | 2003-01-28 | Institute Of Molecular Agrobiology | RANK1, an ankyrin-repeat containing peptide from rice associated with disease resistance |
| WO2015017786A1 (en) * | 2013-08-02 | 2015-02-05 | Cornell University | Increasing leaf longevity and disease resistance by altering salicylic acid catabolism |
| US9873889B2 (en) | 2013-08-02 | 2018-01-23 | Cornell University | Increasing leaf longevity and disease resistance by altering salicylic acid catabolism |
Also Published As
| Publication number | Publication date |
|---|---|
| IL132762A0 (en) | 2001-03-19 |
| AU7487598A (en) | 1998-12-08 |
| CA2289751A1 (en) | 1998-11-19 |
| JP2001525674A (en) | 2001-12-11 |
| NZ500887A (en) | 2002-02-01 |
| EP0981623A1 (en) | 2000-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0800582B1 (en) | Transgenic plants expressing dna constructs containing a plurality of genes to impart virus resistance | |
| US5583021A (en) | Production of virus resistant plants | |
| US6252138B1 (en) | Pathogen-induced plant promoters | |
| CA2112999C (en) | Pathogen-resistant transgenic plants | |
| US8334427B2 (en) | Induction of Xa27 by the avrXa27 gene in rice confers broad-spectrum resistance to Xanthomonas oryzae pv. oryzae and enhanced resistance to Xanthomonas oryzae pv. oryzicola | |
| US7138273B2 (en) | Method of identifying non-host plant disease resistance genes | |
| EP0680514A1 (en) | Nematode-resistant transgenic plants | |
| JP2003505076A (en) | Arabidopsis thaliana cyclic nucleotide gated ion channel / DND gene; regulator of plant disease resistance and cell death | |
| US6479731B1 (en) | Pi-ta gene conferring fungal disease resistance to plants | |
| AU707935B2 (en) | Transgenic plants exhibiting heterologous virus resistance | |
| CA2678955A1 (en) | Identification of a candidate resistance gene to blackleg (leptospherea maculans) in canola (brassica napus) | |
| US20020059660A1 (en) | Transgenic plants expressing DNA constructs containing a plurality of genes to impart virus resistance | |
| US5898097A (en) | Resistance to virus infection using modified viral movement protein | |
| EP0981623A1 (en) | Gene encoding for systemic acquired resistance in arabidopsis | |
| MXPA99010515A (en) | Gene encoding for systemic acquired resistance in arabidopsis | |
| WO2004099417A1 (en) | Genetic sequences of plant pathogen avirulence genes and uses therefor | |
| Catranis | Transgenic hybrid poplar expressing genes encoding antimicrobial peptides | |
| AU2004236279A1 (en) | Genetic sequences of plant pathogen avirulence genes and uses therefor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WWE | Wipo information: entry into national phase |
Ref document number: 132762 Country of ref document: IL |
|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA IL JP MX NZ US |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| WWE | Wipo information: entry into national phase |
Ref document number: 500887 Country of ref document: NZ |
|
| ENP | Entry into the national phase |
Ref document number: 2289751 Country of ref document: CA Ref country code: JP Ref document number: 1998 549544 Kind code of ref document: A Format of ref document f/p: F Ref country code: CA Ref document number: 2289751 Kind code of ref document: A Format of ref document f/p: F |
|
| WWE | Wipo information: entry into national phase |
Ref document number: PA/a/1999/010515 Country of ref document: MX |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 74875/98 Country of ref document: AU |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 1998922292 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 09423787 Country of ref document: US |
|
| WWP | Wipo information: published in national office |
Ref document number: 1998922292 Country of ref document: EP |
|
| WWW | Wipo information: withdrawn in national office |
Ref document number: 1998922292 Country of ref document: EP |